DJIA 15,303.65 -14.58 -0.10%
NASDAQ 3,480.27 -1.91 -0.05%
S&P 500 1,650.34 -1.47 -0.09%
market minute promo

Johnson & Johnson

NYSE: JNJ

85.99 -0.37 (-0.43%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JNJ $85.94 -0.49%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $86.43
Previous Close $86.36
Daily Range $85.90 - $86.46
52-Week Range $66.14 - $89.99
Market Cap $241.5B
P/E Ratio 23.53
Dividend (Yield) $2.64 (3.1%)
Ex-Dividend Date
Dividend Pay Date
05/23/13
06/11/13
Volume 1,558,818
Average Daily Volume 9,644,735
Current FY EPS $5.42

Sector

Healthcare

Industry

Drugs

Johnson & Johnson (JNJ) Description

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices. Website: http://www.jnj.com/

News & Commentary

The Top 3 Medical Uses of Botox

Despite being well-known for curing wrinkles, Botox has important therapeutic uses, too.

Medivation's Xtandi Threatened By Johnson & Johnson's New Acquisition

Johnson & Johnson: Aragon Pharmaceuticals Is An Excellent Addition For Its Oncology Unit

One Simple Measure for Investing in a Volatile Market

J&J to Buy Aragon for $1 Billion - Analyst Blog

J&J to Buy Aragon for $1 Billion - Analyst Blog

The FDA Might Pull This Drug From the Market (and Why It Doesn't Matter)

Two deaths after patients take Eli Lilly's Zyprexa Relprevv.

An Interview With Elemer Piros: A Strong Year For Biotechs, Looking From The Halfway Point

Johnson & Johnson Gets Key Cancer Drug With Aragon Buy

Buy-Rated Dow Components Slip To Ten

Merger Monday: 2 Blue Chips Making Smart Buys

For once, it isn't about empire-building.

See More JNJ News...

JNJ's Top Competitors

JNJ $85.99 (-0.43%)
Current stock: JNJ
MRK $47.85 (0.21%)
Current stock: MRK
ABT $36.93 (-1.55%)
Current stock: ABT
PFE $29.48 (0.27%)
Current stock: PFE